Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$627M |
| 2 |
Baidu
BIDU
|
+$542M |
| 3 |
iShares MBS ETF
MBB
|
+$492M |
| 4 |
NVIDIA
NVDA
|
+$429M |
| 5 |
Comcast
CMCSA
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.29B |
| 2 |
DuPont de Nemours
DD
|
+$635M |
| 3 |
Broadcom
AVGO
|
+$398M |
| 4 |
Eli Lilly
LLY
|
+$394M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.73% |
| 2 | Healthcare | 3.22% |
| 3 | Consumer Discretionary | 2.4% |
| 4 | Financials | 2.32% |
| 5 | Industrials | 1.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
CALL
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.51B
| $10.7M | ﹤0.01% |
239,600
+127,600
| +114% | +$5.5M |
|
2752
PUT
Vanguard FTSE Emerging Markets ETF
VWO
$123B
| $10.6M | ﹤0.01% |
204,600
-295,100
| -59% | -$15.7M |
|
|
JKS
2753
PUT
JinkoSolar
JKS
$826M
| $10.6M | ﹤0.01% |
255,200
+78,500
| +44% | +$4.4M |
|
|
SKX
2754
DELISTED
Skechers
SKX
| $10.6M | ﹤0.01% |
254,525
-249,532
| -50% | -$9.42M |
|
2755
NextCure
NXTC
$21.4M
| $10.6M | ﹤0.01% |
88,368
-1,119
| -1% | -$162K |
|
|
GNMK
2756
DELISTED
GenMark Diagnostics, Inc
GNMK
| $10.6M | ﹤0.01% |
443,189
+332,232
| +299% | +$6.17M |
|
2757
CALL
Pacific Biosciences
PACB
$404M
| $10.6M | ﹤0.01% |
317,900
+52,600
| +20% | +$1.84M |
|
|
LHC
2758
DELISTED
Leo Holdings Corp. II
LHC
| $10.6M | ﹤0.01% |
+1,088,073
| New | +$10.7M |
|
2759
Manhattan Associates
MANH
$11.2B
| $10.6M | ﹤0.01% |
90,069
+73,258
| +436% | +$8.87M |
|
|
MZTI
2760
The Marzetti Company
MZTI
$3.05B
| $10.6M | ﹤0.01% |
60,274
-138,837
| -70% | -$24.9M |
|
2761
Cognex
CGNX
$11.8B
| $10.6M | ﹤0.01% |
127,321
+67,471
| +113% | +$5.62M |
|
2762
PUT
Ziff Davis
ZD
$1.94B
| $10.6M | ﹤0.01% |
101,315
+86,135
| +567% | +$8.11M |
|
2763
EyePoint Inc
EYPT
$1.03B
| $10.5M | ﹤0.01% |
1,035,604
+1,021,727
| +7,363% | +$11.5M |
|
2764
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.35B
| $10.5M | ﹤0.01% |
106,630
-17,948
| -14% | -$1.74M |
|
|
BTAQ
2765
DELISTED
Burgundy Technology Acquisition Corporation Class A Ordinary shares
BTAQ
| $10.5M | ﹤0.01% |
1,062,346
-737,654
| -41% | -$7.83M |
|
|
PGRE
2766
DELISTED
Paramount Group
PGRE
| $10.5M | ﹤0.01% |
1,036,172
-276,090
| -21% | -$2.59M |
|
|
GLS
2767
DELISTED
Gelesis Holdings, Inc.
GLS
| $10.5M | ﹤0.01% |
1,074,762
+124,762
| +13% | +$1.28M |
|
2768
Inseego
INSG
$121M
| $10.5M | ﹤0.01% |
104,792
+54,084
| +107% | +$7.88M |
|
2769
PUT
Bloomin' Brands
BLMN
$1.01B
| $10.5M | ﹤0.01% |
386,500
-861,500
| -69% | -$20.9M |
|
|
NXU.U
2770
DELISTED
Novus Capital Corporation II Units, each consisting of one share of Class A common stock and one thi
NXU.U
| $10.4M | ﹤0.01% |
+1,044,924
| New | +$10.9M |
|
2771
CALL
Arrowhead Research
ARWR
$12.2B
| $10.4M | ﹤0.01% |
157,500
-77,400
| -33% | -$6.01M |
|
|
TWCT
2772
DELISTED
TWC Tech Holdings II Corp. Class A Common Stock
TWCT
| $10.4M | ﹤0.01% |
1,060,449
+306,364
| +41% | +$3.21M |
|
2773
Shoals Technologies Group
SHLS
$1.46B
| $10.4M | ﹤0.01% |
+299,907
| New | +$10.6M |
|
2774
PUT
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$309M
| $10.4M | ﹤0.01% |
479,700
-30,200
| -6% | -$585K |
|
2775
Bank OZK
OZK
$5.63B
| $10.4M | ﹤0.01% |
254,980
-365,731
| -59% | -$14.4M |
|
Similar funds
Citadel Advisors's Q1 2021 Portfolio in Review
As of Q1 2021, Citadel Advisors held 14,143 positions worth $408B, up 6% from $385B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citadel Advisors's Q1 2021 filing shows 3,278 new, 5,446 increased, 4,187 reduced and 1,034 closed positions. Its largest new stake was SVB Financial Group: 445,853 shares worth $220M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.29B.
By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3.7% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Citadel Advisors's largest Q1 2021 buy was SVB Financial Group: 445,853 shares worth $220M.
- Citadel Advisors added most to Amazon in Q1 2021, an estimated $627M increase.
- Citadel Advisors's biggest Q1 2021 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.29B.
- Citadel Advisors fully exited iShares MSCI Emerging Markets ETF in Q1 2021, selling an estimated $321M.
- Citadel Advisors's ten largest holdings make up 28% of its $408B portfolio in Q1 2021.
- Citadel Advisors opened 3,278 new positions and closed 1,034 in Q1 2021.
- Citadel Advisors's portfolio value rose 6% quarter-over-quarter to $408B.
Based on Citadel Advisors's 13F filing for Q1 2021, filed 17 May 2021.